NPDPSC Personnel
| Name | Position | Role |
|---|---|---|
| Dr. Jiri Safar | Director | General oversight of NPDPSC, including all administrative functions, staff, and budget. General scientific leadership. Direct oversight of immunodiagnostic and molecular typing of human prions including neuropathology, DNA sequencing, and WBs. Development of new rapid diagnostic and molecular typing methods based on conformation-dependent immunoassay (CDI). |
| Dr. Mark Cohen | Co-Director | Clinical neuropathology – histopathological and immunohistochemical diagnostics. |
| Dr. Brian Appleby | Co-Director | Clinical follow-up and diagnostics for human prion cases. Relations with caregivers and patient families. Together with the NPDPSC manager, nurture relationships with surveillance personnel of state public health departments, neurologists, other medical care personnel, and the CJD Foundation. |
| Dr. Daniel Rhoads | Co-Director | Clinical Laboratory Director; CLIA regulatory issues and certification; technical responsibility for clinical activities and quality control of diagnostic CSF prion tests. |
| Dr. Wenquan Zou | Associate Director | Western blot prion strain typing. |
| Andrea Webb | Manager | Provides financial, operational, supervisory and program/grant management support, ensuring the smooth functioning of the center and its programs. |
Contact Information for the NPDPSC:
Phone: 216-368-0587
Email:cjdsurveillance@case.edu